BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26730524)

  • 1. Hepatobiliary and Pancreatic: Dual system stenting of the biliary and porto-venous systems to palliate locoregional recurrence of hilar cholangiocarcinoma.
    Chua TC; Roseverne LO; Goh AC; Maher R; Samra JS
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1239. PubMed ID: 26730524
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal vein stenting for portal vein stenosis caused by bile duct cancer.
    Kamata K; Takenaka M; Tsurusaki M; Kudo M
    Dig Liver Dis; 2017 Nov; 49(11):1282. PubMed ID: 28676419
    [No Abstract]   [Full Text] [Related]  

  • 3. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
    Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
    Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disastrous Portal Vein Embolization Turned into a Successful Intervention.
    Dobrocky T; Kettenbach J; Lopez-Benitez R; Kara L
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1365-8. PubMed ID: 25212417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous transhepatic portal vein stenting for malignant portal vein stenosis secondary to recurrent perihilar biliary cancer.
    Mizuno T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mori Y; Suzuki K; Nagino M
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):740-5. PubMed ID: 26084448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hilar tumours.
    Costamagna G; Tringali A; Petruzziello L; Spada C
    Can J Gastroenterol; 2004 Jul; 18(7):451-4. PubMed ID: 15229747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placement of ¹²⁵I seed strands and stents for a type IV Klatskin tumor.
    Zhang W; Yang ZQ; Shi HB; Liu S; Zhou WZ; Zhao LB
    World J Gastroenterol; 2015 Jan; 21(1):373-6. PubMed ID: 25574114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hilar cholangiocarcinoma (Klatskin's tumor): up-to-date radiologic diagnosis, intervention and treatment possibilities].
    Goltz JP; Kenn W; Hahn D; Ritter CO
    Dtsch Med Wochenschr; 2009 May; 134(19):985-8. PubMed ID: 19401964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatobiliary and Pancreatic: Portal vein stent for local recurrence of bile duct cancer.
    Matsumura K; Hashimoto D; Umezaki N; Nakagawa S; Chikamoto A; Yamashita Y; Ikeda O; Yamashita Y; Baba H
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1425. PubMed ID: 28752686
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous unilateral placement of biliary covered metallic stent in patients with malignant hilar biliary obstruction and contralateral portal vein occlusion.
    Yi R; Gwon DI; Ko GY; Yoon HK; Kim JH; Shin JH; Sung KB
    Acta Radiol; 2012 Sep; 53(7):742-9. PubMed ID: 22850575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can unilateral stent placement be adequate in patients with Klatskin tumors of Bismuth-type III and IV?
    Shah SK; Costamagna G
    Gastrointest Endosc; 2001 Dec; 54(6):804-5. PubMed ID: 11726870
    [No Abstract]   [Full Text] [Related]  

  • 12. Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol.
    Bhat M; Hathcock M; Kremers WK; Darwish Murad S; Schmit G; Martenson J; Alberts S; Rosen CB; Gores GJ; Heimbach J
    Transpl Int; 2015 Dec; 28(12):1383-91. PubMed ID: 26183487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of stent-grafts in treatment of porto-biliary fistula.
    Peynircioglu B; Cwikiel W
    Cardiovasc Intervent Radiol; 2006; 29(6):1156-9. PubMed ID: 16897266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Portal vein stenting as a bridge to chemotherapy for perihilar cancer with portal vein stenosis - a case report].
    Tsukamoto T; Kanazawa A; Shimizu S; Sakae M; Kurihara S; Tashima T; Deguchi S; Goto W; Kotsuka M; Ishikawa A; Yoshii M; Nakajima T; Mori Y; Ohira G; Tachimori A; Tamamori Y; Yamamoto A; Inoue T; Yamashita Y; Nishiguchi Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1539-41. PubMed ID: 25731245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma at the hepatic hilus: sonographic findings.
    Hann LE; Greatrex KV; Bach AM; Fong Y; Blumgart LH
    AJR Am J Roentgenol; 1997 Apr; 168(4):985-9. PubMed ID: 9124155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hilar cholangiocarcinoma: expert consensus statement.
    Mansour JC; Aloia TA; Crane CH; Heimbach JK; Nagino M; Vauthey JN
    HPB (Oxford); 2015 Aug; 17(8):691-9. PubMed ID: 26172136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hilar cholangiocarcinoma (Klatskin tumor) - current treatment options].
    Bělina F
    Rozhl Chir; 2013 Jan; 92(1):4-15. PubMed ID: 23578293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon dilatation through the subcutaneously placed afferent limb of a hepaticojejunostomy in patients with resected Klatskin tumors.
    Hutson DG; Russell E; Levi JU; Livingstone AS; Yrizarry JM; Guerra J; Scagnelli T
    Am Surg; 1995 Jun; 61(6):518-20. PubMed ID: 7539232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal vein invasion by intrahepatic peripheral cholangiocarcinoma: a rare cause of portal hypertension.
    Soyer P; Pelage JP; Zidi SH; Boudiaf M; Rymer R
    AJR Am J Roentgenol; 1998 Nov; 171(5):1413-4. PubMed ID: 9798888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Palliative locoregional therapy for hilar cholangiocarcinoma: photodynamic therapy and brachytherapy].
    Dumoulin FL; Horst E; Sauerbruch T; Gerhardt T
    Zentralbl Chir; 2007 Aug; 132(4):336-41. PubMed ID: 17724637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.